N

Navamedic ASA
OSE:NAVA

Watchlist Manager
Navamedic ASA
OSE:NAVA
Watchlist
Price: 23.9 NOK -2.85%
Market Cap: 422.1m NOK
Have any thoughts about
Navamedic ASA?
Write Note

Navamedic ASA
Investor Relations

Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The firm in-licenses, acquires and markets pharmaceuticals and other healthcare products in northern Europe. The product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices and other healthcare products. Navamedic ASA has three subsidiaries: Observe Medical, a Swedish medical technology company; Vitaflo Scandinavia AB, which focuses on in-licensing and buying pharmaceuticals and other healthcare products within a few selected knowledge areas; and Navamedic ehf, which builds its business around the sales and marketing of generic pharmaceuticals targeted towards the Nordic and BeNeLux markets. The Navamedic business unit is built upon the cooperation with the South African pharmaceutical company Aspen Healthcare. The Company’s largest shareholder is Nobelsystem Scandinavia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Ms. Kathrine E. Gamborg Andreassen
Chief Executive Officer
No Bio Available
Mr. Lars Hjarrand
Chief Financial Officer
No Bio Available
Mr. Alexander Lidmejer
Chief Operating Officer
No Bio Available
Ms. Astrid J. Torgersen Bratvedt
Chief Scientific Officer
No Bio Available
Mr. Ole Henrik Eriksen
Chief Business Development Officer
No Bio Available

Contacts

Address
OSLO
Oslo
Henrik Ibsensgate 90
Contacts
+4767112540.0
www.navamedic.com